Sex‐specific differences in GABAA‐benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving

Sex differences exist in tobacco smoking behaviors. Nicotine, the primary addictive ingredient in tobacco smoke, indirectly affects γ‐amino butyric acid (GABA) function. Previous studies reported sex‐by‐smoking interactions in brain GABA levels. The goal of the present study was to evaluate if there is a sex‐by‐smoking interaction at the GABAA‐benzodiazepine receptors (GABAA‐BZRs), as well as relationships between GABAA‐BZR availability and behavioral variables before and after 1 week of smoking cessation. Twenty‐six women (8 non‐smokers, age 36.0 ± 13.4 years; 19 smokers, age 34.6 ± 8.9 years) and 25 men (8 non‐smokers, age 37.9 ± 13.8 years; 17 smokers, 34.1 ± 12.4 years) were imaged using [123I]iomazenil and single‐photon emission computed tomography. Smokers were imaged at baseline 7 hours after the last cigarette. A significantly great number of men were able to abstain from smoking for 1 week (P = 0.003). There were no significant differences in nicotine dependence and cigarette craving, mood or pain sensitivity between male and female smokers. There was a significant effect of gender across all brain regions (frontal, parietal, anterior cingulate, temporal and occipital cortices, and cerebellum; P < 0.05), with all women (smokers and non‐smokers combined) having a higher GABAA‐BZR availability than all men. There was a negative correlation between GABAA‐BZR availability and craving (P ≤ 0.02) and pain sensitivity (P = 0.04) in female smokers but not male smokers. This study provides further evidence of a sex‐specific regulation of GABAA‐BZR availability in humans and demonstrates the potential for GABAA‐BZRs to mediate tobacco smoking craving and pain symptoms differentially in female and male smokers.

[1]  R. Makuch,et al.  GABAA‐benzodiazepine receptor availability in smokers and nonsmokers: Relationship to subsyndromal anxiety and depression , 2009, Synapse.

[2]  S. Petersen,et al.  Central role of TRAF-interacting protein in a new model of brain sexual differentiation , 2009, Proceedings of the National Academy of Sciences.

[3]  Qiuling Xiang,et al.  Modulatory role of estradiol in nicotinic antinociception in adult female rats. , 2009, Life sciences.

[4]  C. Mazure,et al.  Gender differences in the comorbidity of smoking behavior and major depression. , 2008, Drug and alcohol dependence.

[5]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Suchitra Krishnan-Sarin,et al.  Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers , 2006, The Journal of Neuroscience.

[7]  J. Seibyl,et al.  Nicotinic Acetylcholine Receptors in Human Brain by the Constant Infusion Paradigm: Feasibility and Reproducibility , 2005 .

[8]  W. Maixner,et al.  Cigarette smoking, stress-induced analgesia and pain perception in men and women , 2005, Pain.

[9]  Ananda Sen,et al.  Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[10]  J. Krystal,et al.  Sex, GABA, and nicotine: The impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy , 2005, Biological Psychiatry.

[11]  J. Krystal,et al.  Cortical γ-Aminobutyric Acid Levels Across the Menstrual Cycle in Healthy Women and Those With Premenstrual Dysphoric Disorder: A Proton Magnetic Resonance Spectroscopy Study , 2002 .

[12]  K. Perkins,et al.  Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[13]  R. Craft,et al.  Sex differences in cocaine- and nicotine-induced antinociception in the rat , 1998, Brain Research.

[14]  P B Hoffer,et al.  Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  L. McMahon,et al.  Nicotinic receptor activation facilitates gabaergic neurotransmission in the avian lateral spiriform nucleus , 1994, Neuroscience.

[16]  J. Seibyl,et al.  SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  C. Mulle,et al.  Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  E. Sybirska,et al.  Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[19]  S. Tiffany,et al.  The development and initial validation of a questionnaire on smoking urges. , 1991, British journal of addiction.

[20]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[21]  N. Walsh,et al.  Normative Model for Cold Pressor Test , 1989, American journal of physical medicine & rehabilitation.

[22]  S. Zorn,et al.  GABA uptake inhibitors produce a greater antinociceptive response in the mouse tail-immersion assay than other types of GABAergic drugs. , 1985, Life sciences.

[23]  L. Costa,et al.  A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen , 1985, Neuropharmacology.

[24]  D. Hatsukami,et al.  Tobacco withdrawal symptoms: An experimental analysis , 1984, Psychopharmacology.

[25]  H. Proudfit,et al.  The analgesic action of baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid]. , 1977, The Journal of pharmacology and experimental therapeutics.

[26]  L. Radloff The CES-D Scale , 1977 .

[27]  N. Rathod Society for the Study of Addiction , 1977 .

[28]  D. Hatsukami,et al.  Tobacco withdrawal symptoms: an experimental analysis , 2005, Psychopharmacology.

[29]  A. Bohadana,et al.  Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[30]  John H Krystal,et al.  Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. , 2002, Archives of general psychiatry.

[31]  M. Damaj Influence of gender and sex hormones on nicotine acute pharmacological effects in mice. , 2001, The Journal of pharmacology and experimental therapeutics.

[32]  Y. Magata,et al.  Effect of chronic (-)-nicotine treatment on rat cerebral benzodiazepine receptors. , 2000, Nuclear medicine and biology.

[33]  J. Henningfield,et al.  Nicotine dependence in women. , 1996, Journal of the American Medical Women's Association.

[34]  N. Grunberg,et al.  Gender differences in tobacco use. , 1991, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[35]  Pomerleau Of Nicotine as a psychoactive drug: anxiety and pain reduction. , 1986 .

[36]  O. Pomerleau,et al.  Nicotine-produced antinociception in minimally deprived smokers and ex-smokers. , 1986, Addictive behaviors.

[37]  O. Pomerleau Nicotine as a psychoactive drug: anxiety and pain reduction. , 1986, Psychopharmacology bulletin.

[38]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .